Image Ben Hargreaves R&D LNPs: The unknown enabler behind mRNA vaccines Drug delivery technologies are crucial to allow drugs to reach their full potential, and yet they rarely receive much spotlight. Sales & Marketing Is the pharma industry particularly vulnerable to inflation? The pharma industry is often thought of as one that does not struggle in difficult economic periods – even when times are hard, everyone still values their health. Oncology The gut microbiome: the next breakthrough in cancer? Ben Hargreaves discovers how research has emerged outlining how the gut microbiome plays a crucial role in patients’ response to cancer treatments. Market Access Capping the cost of insulin: altruistic or strategic? The price of insulin has become one of the most talked about issues across the pharma industry. Load more results
R&D LNPs: The unknown enabler behind mRNA vaccines Drug delivery technologies are crucial to allow drugs to reach their full potential, and yet they rarely receive much spotlight.
Sales & Marketing Is the pharma industry particularly vulnerable to inflation? The pharma industry is often thought of as one that does not struggle in difficult economic periods – even when times are hard, everyone still values their health.
Oncology The gut microbiome: the next breakthrough in cancer? Ben Hargreaves discovers how research has emerged outlining how the gut microbiome plays a crucial role in patients’ response to cancer treatments.
Market Access Capping the cost of insulin: altruistic or strategic? The price of insulin has become one of the most talked about issues across the pharma industry.
News Alzheimer's biotech Korsana to go public via reverse merger By merging with Cyclerion, Korsana will get a Nasdaq listing and additional cash to develop its new-generation amyloid-targeting drug for Alzheimer's.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.